Bartlett SR; Yu A; Chapinal N; Rossi C; Butt Z; Wong S; Darvishian M; Gilbert M; Wong J; Binka M, 2019, 'The population level care cascade for hepatitis C in British Columbia, Canada as of 2018: Impact of direct acting antivirals', Liver International, http://dx.doi.org/10.1111/liv.14227
Darvishian M; Wong S; Binka M; Yu A; Ramji A; Yoshida EM; Wong J; Rossi C; Butt ZA; Bartlett S, 2019, 'Loss to follow-up: A significant barrier in the treatment cascade with direct-acting therapies.', J Viral Hepat, http://dx.doi.org/10.1111/jvh.13228
Rossi C; Jeong D; Wong S; McKee G; Butt ZA; Buxton J; Wong J; Darvishian M; Bartlett S; Samji H, 2019, 'Sustained virological response from interferon-based hepatitis C regimens is associated with reduced risk of extrahepatic manifestations', Journal of Hepatology, vol. 71, pp. 1116 - 1125, http://dx.doi.org/10.1016/j.jhep.2019.07.021
Martinello M; Yee J; Bartlett SR; Read P; Baker D; Post JJ; Finlayson R; Bloch M; Doyle J; Shaw D, 2019, 'Moving towards hepatitis C micro-elimination among people living with HIV in Australia: the CEASE study.', Clin Infect Dis, http://dx.doi.org/10.1093/cid/ciz985
Bartlett SR; Buller-Taylor T; Krajden M; Janjua NZ, 2019, 'Using population-level integrated health data to monitor and assess patients’ progression across care and treatment continuums', British Columbia Medical Journal, vol. 61
Bartlett SR; Applegate TL; Jacka BP; Martinello M; Lamoury FMJ; Danta M; Bradshaw D; Shaw D; Lloyd AR; Hellard M, 2019, 'A latent class approach to identify multi-risk profiles associated with phylogenetic clustering of recent hepatitis C virus infection in Australia and New Zealand from 2004 to 2015', Journal of the International AIDS Society, vol. 22, http://dx.doi.org/10.1002/jia2.25222
Bartlett SR; Fox P; Cabatingan H; Jaros A; Gorton C; Lewis R; Priscott E; Dore GJ; Russell DB, 2018, 'Demonstration of near-elimination of Hepatitis C virus among a prison population: The Lotus Glen Correctional Centre Hepatitis C Treatment Project', Clinical Infectious Diseases, vol. 67, pp. 460 - 463, http://dx.doi.org/10.1093/cid/ciy210
Bartlett SR; Grebely J; Eltahla AA; Reeves JD; Howe AYM; Miller V; Ceccherini-Silberstein F; Bull RA; Douglas MW; Dore GJ, 2017, 'Sequencing of hepatitis C virus for detection of resistance to direct-acting antiviral therapy: A systematic review.', Hepatol Commun, vol. 1, pp. 379 - 390, http://dx.doi.org/10.1002/hep4.1050
Bartlett SR; Wertheim JO; Bull RA; Matthews GV; Lamoury FMJ; Scheffler K; Hellard M; Maher L; Dore GJ; Lloyd AR, 2017, 'A molecular transmission network of recent hepatitis C infection in people with and without HIV: Implications for targeted treatment strategies', Journal of Viral Hepatitis, vol. 24, pp. 404 - 411, http://dx.doi.org/10.1111/jvh.12652
Bartlett SR; Jacka B; Bull RA; Luciani F; Matthews GV; Lamoury FMJ; Hellard ME; Hajarizadeh B; Teutsch S; White B, 2016, 'HIV infection and hepatitis C virus genotype 1a are associated with phylogenetic clustering among people with recently acquired hepatitis C virus infection', Infection, Genetics and Evolution, vol. 37, pp. 252 - 258, http://dx.doi.org/10.1016/j.meegid.2015.11.028
Lamoury FMJ; Bartlett S; Jacka B; Hajarizadeh B; Grebely J; Matthews GV; Dore GJ; Applegate TL, 2015, 'Interferon λ 3 and 4 genotyping using high-resolution melt curve analysis suitable for multiple clinical sample types', Journal of Molecular Diagnostics, vol. 17, pp. 583 - 589, http://dx.doi.org/10.1016/j.jmoldx.2015.05.003
Lamoury FMJ; Jacka B; Bartlett S; Bull RA; Wong A; Amin J; Schinkel J; Poon AF; Matthews GV; Grebely J, 2015, 'The influence of hepatitis C virus genetic region on phylogenetic clustering analysis', PLoS ONE, vol. 10, http://dx.doi.org/10.1371/journal.pone.0131437
Bartlett SR; Seeliger J; Burnell JN, 2012, 'Identification of critical residues in the bifunctional phosphoenolpyruvate synthetase kinase/phosphotransferase of Escherichia coli', Current Topics in Biochemical Research, vol. 14, pp. 77 - 83
Darvishian M; Rossi C; Wong S; Yu A; Woods R; Binka M; Butt ZA; Buxton J; Bartlett S; Pearce M, 2019, 'Cancer risk among people with HIV, HBV, and/or HCV infections', in JOURNAL OF HEPATOLOGY, ELSEVIER, Vienna, AUSTRIA, pp. E328 - E329, presented at International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Vienna, AUSTRIA, 10 - 14 April 2019, http://dx.doi.org/10.1016/S0618-8278(19)30642-5
Janjua N; Wong S; Rossi C; Darvishian M; Yu A; Butt ZA; Yoshida E; Ramji A; Feld J; Binka M, 2019, 'The impact of SVR from direct acting antiviral and interferon-based treatments for HCV on hepatocellular carcinoma risk in a large population based cohort', in JOURNAL OF HEPATOLOGY, ELSEVIER, Vienna, AUSTRIA, pp. E736 - E736, presented at International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Vienna, AUSTRIA, 10 - 14 April 2019, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000463481703228&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Bartlett S; Wong S; Yu A; Alvarez M; Buller-Taylor T; Butt ZA; Darvishian M; Rossi C; Binka M; Pearce M, 2019, 'Factors associated with hepatitis C treatment uptake among people who inject drugs in a population based data linkage study', in JOURNAL OF HEPATOLOGY, ELSEVIER, Vienna, AUSTRIA, pp. E210 - E211, presented at International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Vienna, AUSTRIA, 10 - 14 April 2019, http://dx.doi.org/10.1016/S0618-8278(19)30393-7
Bartlett S; Wong S; Alvarez M; Buller-Taylor T; Butt Z; Darvishian M; Rossi C; Pearce M; Wong J; Mark G, 2019, 'Integrating health and administrative datasets to improve quality of care: The BC-HTC', British Columbia Quality Forum 2019, Vancouver, Canada, presented at British Columbia Quality Forum 2019, Vancouver, Canada, 26 - 28 February 2019
Bartlett SR, 2017, Molecular epidemiology of recently acquired hepatitis C virus infection in Australia
Hooshyar SH; Martinello M; Yee J; Bartlett S; Read P; Baker D; Post J; Finlayson R; Bloch M; Doyle J, 2019, 'Low HCV reinfection incidence following DAA treatment scale-up in people living with HIV in Australia', in JOURNAL OF HEPATOLOGY, ELSEVIER, Vienna, AUSTRIA, Vol. 70, pp. E734 - E734, presented at International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Vienna, AUSTRIA, 10 - 14 April 2019, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000463481703225&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Martinello M; Bartlett S; Dore G; Bopage R; Finlayson R; Baker D; Bloch M; Doyle J; Shaw D; Hajkowicz K, 2018, 'Universal access to DAA therapy paves the way for HCV control and elimination among people living with HIV in Australia', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, Paris, FRANCE, Vol. 68, pp. S312 - S313, presented at International Liver Congress (ILC), Paris, FRANCE, 11 - 15 April 2018, http://dx.doi.org/10.1016/S0168-8278(18)30843-2
Bartlett SR; Grebely J; Eltahla AA; Reeves JD; Howe A; Miller V; Bull RA; Ceccherini-Silberstein F; Douglas MW; Dore GJ, 2017, 'Systematic review & expert guidance on methods for sequencing of hepatitis C virus for detection of direct-acting antiviral resistance', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, Amsterdam, NETHERLANDS, Vol. 66, pp. S323 - S323, presented at International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Amsterdam, NETHERLANDS, 19 - 23 April 2017, http://dx.doi.org/10.1016/S0168-8278(17)30970-4
